Does AREDS2 work in dry age-related macular degeneration?
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
The AREDS2 supplement appears to modestly slow the progression of intermediate dry AMD, especially in patients already at higher risk, but does not affect early-stage progression.
Fields of Study & Subjects
Retinal Diseases and Treatments
Retinal Imaging and Analysis
Ocular Surface and Contact Lens
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 30 March 2026
- Language
- EN